Streetbeat News

Analyst Ratings

BL

BlackLine (NASDAQ:BL) has received mixed analyst ratings in the last quarter, with 1 bullish, 2 indifferent, and 1 somewhat bearish. The average price target is $58.25, indicating potential upside from the current price of $48.93. However, this average has decreased by 3.32% from the previous target of $60.25.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 9:00 pm

SHAK

Shake Shack (NYSE:SHAK) has received 18 analyst ratings in the last quarter, with the majority being indifferent. The average price target is $76.11, a 14.31% increase from the previous average of $66.58. The current price of Shake Shack is $75.6.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 9:00 pm

BXP

Boston Props (NYSE:BXP) has received one somewhat bullish and three indifferent analyst ratings in the last quarter. The average 12-month price target for the company, according to four analysts, is $66.25, with a high of $80.00 and a low of $52.00. This average price target has increased by 2.32% over the past month.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 9:00 pm

FRPT

Freshpet (NASDAQ:FRPT) has received various analyst ratings in the last quarter, with 2 bullish, 2 somewhat bullish, and 3 indifferent. The company's average price target has increased by 25.73% from the previous average, now standing at $91.57. The high and low price targets are $100.00 and $80.00 respectively.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 9:00 pm

ZVIA

Over the past 3 months, 7 analysts have published their opinion on Zevia (NYSE:ZVIA) stock. The average price target is $4.32, implying an upside from the current price of $2.66. This represents a 15.29% decrease from the previous average price target of $5.10.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 9:00 pm

SOVO

Over the past 3 months, 10 analysts have published their opinion on Sovos Brands (NASDAQ:SOVO) stock. The average price target is $22.7, slightly above the current price of $22.53. The average price target has increased by 10.19% over the past month.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 9:00 pm

NLS

Nautilus (NYSE:NLS) reported Q1 losses of $(0.15) per share, beating the analyst consensus estimate of $(0.44) by 65.91%. However, the company's quarterly sales of $41.75 million missed the analyst consensus estimate of $44.88 million by 6.97%. This represents a 23.84% decrease over sales of $54.82 million the same period last year.

Portfolio Pulse from sunil@benzinga.com

August 09, 2023 | 8:59 pm

ARAY

Accuray (NASDAQ:ARAY) reported Q4 losses of $(0.03) per share, missing the analyst consensus estimate of $0.01 by 400 percent. This is a 25 percent increase over losses from the same period last year. The company also reported quarterly sales of $118.29 million, missing the analyst consensus estimate of $121.74 million by 2.83 percent, but a 7.52 percent increase over sales from the same period last year.

Portfolio Pulse from vinayak@benzinga.com

August 09, 2023 | 8:54 pm

TELA

TELA Bio reported Q2 earnings with losses of $(0.46) per share, beating the analyst consensus estimate of $(0.53) by 13.21%. This is a 47.73% increase over losses from the same period last year. The company also reported quarterly sales of $14.49 million, beating the estimate of $14.40 million by 0.65%, a 39.29% increase over sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 8:53 pm

PLRX

Pliant Therapeutics (NASDAQ:PLRX) reported Q2 losses of $(0.70) per share, beating the analyst consensus estimate of $(0.71) by 1.41%. However, the company's quarterly sales of $248.00K missed the analyst consensus estimate of $880.00K by 71.82%. This represents a 95.03% decrease over sales of $4.99M in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 8:52 pm